ALMS
Price
$4.70
Change
-$0.22 (-4.47%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
484.99M
76 days until earnings call
SLXN
Price
$7.74
Change
+$0.48 (+6.61%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
5.66M
Interact to see
Advertisement

ALMS vs SLXN

Header iconALMS vs SLXN Comparison
Open Charts ALMS vs SLXNBanner chart's image
Alumis
Price$4.70
Change-$0.22 (-4.47%)
Volume$25.56K
Capitalization484.99M
Silexion Therapeutics
Price$7.74
Change+$0.48 (+6.61%)
Volume$300
Capitalization5.66M
ALMS vs SLXN Comparison Chart in %
Loading...
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALMS vs. SLXN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALMS is a StrongBuy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ALMS: $4.92 vs. SLXN: $7.26)
Brand notoriety: ALMS and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALMS: 82% vs. SLXN: 19%
Market capitalization -- ALMS: $484.99M vs. SLXN: $5.66M
ALMS [@Biotechnology] is valued at $484.99M. SLXN’s [@Biotechnology] market capitalization is $5.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALMS’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ALMS’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ALMS is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALMS’s TA Score shows that 5 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ALMS’s TA Score: 5 bullish, 4 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than ALMS.

Price Growth

ALMS (@Biotechnology) experienced а +11.56% price change this week, while SLXN (@Biotechnology) price change was +6.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

ALMS is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALMS($485M) has a higher market cap than SLXN($5.66M). ALMS YTD gains are higher at: -37.405 vs. SLXN (-75.920). SLXN has higher annual earnings (EBITDA): -17.81M vs. ALMS (-435.74M). ALMS has more cash in the bank: 486M vs. SLXN (3.47M). SLXN has less debt than ALMS: SLXN (3.7M) vs ALMS (38.8M). ALMS has higher revenues than SLXN: ALMS (20.1M) vs SLXN (0).
ALMSSLXNALMS / SLXN
Capitalization485M5.66M8,570%
EBITDA-435.74M-17.81M2,446%
Gain YTD-37.405-75.92049%
P/E Ratio0.14N/A-
Revenue20.1M0-
Total Cash486M3.47M14,022%
Total Debt38.8M3.7M1,049%
TECHNICAL ANALYSIS
Technical Analysis
ALMSSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
35%
Momentum
ODDS (%)
Bullish Trend 7 days ago
74%
Bearish Trend 2 days ago
22%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
28%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
27%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 2 days ago
53%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 4 days ago
38%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UGRO0.430.03
+6.99%
urban-gro
BALY10.090.20
+2.02%
Bally's Corporation
FBNC55.300.43
+0.78%
First Bancorp
GLPI47.950.20
+0.42%
Gaming and Leisure Properties
GOCO5.30-0.11
-2.03%
GoHealth

ALMS and

Correlation & Price change

A.I.dvisor tells us that ALMS and ADAP have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALMS and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
+2.93%
ADAP - ALMS
29%
Poorly correlated
+2.93%
ATXS - ALMS
26%
Poorly correlated
-2.40%
ELEV - ALMS
24%
Poorly correlated
N/A
HALO - ALMS
24%
Poorly correlated
+0.34%
OABI - ALMS
23%
Poorly correlated
N/A
More

SLXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLXN has been loosely correlated with IMA. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SLXN jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
+0.83%
IMA - SLXN
63%
Loosely correlated
+0.07%
CELC - SLXN
50%
Loosely correlated
+1.01%
MRSN - SLXN
43%
Loosely correlated
-0.26%
CHRS - SLXN
26%
Poorly correlated
+0.88%
QSI - SLXN
25%
Poorly correlated
-0.85%
More